Viewing Study NCT07185269


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-29 @ 3:59 AM
Study NCT ID: NCT07185269
Status: RECRUITING
Last Update Posted: 2025-11-26
First Post: 2025-09-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module